These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 24127332

  • 1. A miRNA signature associated with human metastatic medullary thyroid carcinoma.
    Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF.
    Endocr Relat Cancer; 2013 Dec; 20(6):809-23. PubMed ID: 24127332
    [Abstract] [Full Text] [Related]

  • 2. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T, Kurashige J, Nambara S, Komatsu H, Hirata H, Ueda M, Sakimura S, Uchi R, Takano Y, Shinden Y, Iguchi T, Eguchi H, Ehata S, Murakami K, Sugimachi K, Mimori K.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [Abstract] [Full Text] [Related]

  • 3. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    Korpal M, Lee ES, Hu G, Kang Y.
    J Biol Chem; 2008 May 30; 283(22):14910-4. PubMed ID: 18411277
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma.
    Chu YH, Hardin H, Schneider DF, Chen H, Lloyd RV.
    Exp Mol Pathol; 2017 Oct 30; 103(2):229-236. PubMed ID: 29107050
    [Abstract] [Full Text] [Related]

  • 5. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Park SM, Gaur AB, Lengyel E, Peter ME.
    Genes Dev; 2008 Apr 01; 22(7):894-907. PubMed ID: 18381893
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y, Baba H.
    Ann Surg Oncol; 2012 Jul 01; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [Abstract] [Full Text] [Related]

  • 7. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN, Cochrane DR, Richer JK.
    Breast Cancer Res; 2011 Apr 18; 13(2):R45. PubMed ID: 21501518
    [Abstract] [Full Text] [Related]

  • 8. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM.
    Br J Cancer; 2011 Nov 22; 105(11):1741-9. PubMed ID: 22033272
    [Abstract] [Full Text] [Related]

  • 9. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.
    Jiang M, Shi X, Zhu H, Wei W, Li J.
    Med Sci Monit; 2019 Jul 12; 25():5170-5180. PubMed ID: 31298226
    [Abstract] [Full Text] [Related]

  • 10. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
    Gundara JS, Zhao JT, Gill AJ, Clifton-Bligh R, Robinson BG, Delbridge L, Sidhu SB.
    ANZ J Surg; 2014 Apr 12; 84(4):235-9. PubMed ID: 23072640
    [Abstract] [Full Text] [Related]

  • 11. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.
    Oncol Rep; 2013 Apr 12; 29(4):1579-87. PubMed ID: 23381389
    [Abstract] [Full Text] [Related]

  • 12. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
    Castilla MÁ, Moreno-Bueno G, Romero-Pérez L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J, Matías-Guiu X, Cano A, Oliva E, Palacios J.
    J Pathol; 2011 Jan 12; 223(1):72-80. PubMed ID: 21125666
    [Abstract] [Full Text] [Related]

  • 13. Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions.
    Liao X, Xue H, Wang YC, Nazor KL, Guo S, Trivedi N, Peterson SE, Liu Y, Loring JF, Laurent LC.
    J Cell Sci; 2013 Sep 01; 126(Pt 17):3848-61. PubMed ID: 23813959
    [Abstract] [Full Text] [Related]

  • 14. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D, Guo J, Wu Y, Du J, Wang X, An J, Hu B, Kong L, Di W, Wang W.
    Theranostics; 2019 Sep 01; 9(7):2036-2055. PubMed ID: 31037155
    [Abstract] [Full Text] [Related]

  • 15. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells.
    Matsushima K, Isomoto H, Yamaguchi N, Inoue N, Machida H, Nakayama T, Hayashi T, Kunizaki M, Hidaka S, Nagayasu T, Nakashima M, Ujifuku K, Mitsutake N, Ohtsuru A, Yamashita S, Korpal M, Kang Y, Gregory PA, Goodall GJ, Kohno S, Nakao K.
    J Transl Med; 2011 Mar 22; 9():30. PubMed ID: 21426561
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X, Roslan S, Johnstone CN, Wright JA, Bracken CP, Anderson M, Bert AG, Selth LA, Anderson RL, Goodall GJ, Gregory PA, Khew-Goodall Y.
    Oncogene; 2014 Jul 31; 33(31):4077-88. PubMed ID: 24037528
    [Abstract] [Full Text] [Related]

  • 18. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
    Yang X, Liu G, Xiao H, Yu F, Xiang X, Lu Y, Li W, Liu X, Li S, Shi Y.
    Pathol Oncol Res; 2014 Jul 31; 20(3):641-8. PubMed ID: 24488334
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.
    Shabani N, Razaviyan J, Paryan M, Tavangar SM, Azizi F, Mohammadi-Yeganeh S, Hedayati M.
    Hum Pathol; 2018 Sep 31; 79():212-221. PubMed ID: 29885402
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.